175 related articles for article (PubMed ID: 25542924)
1. Screening for carcinoma in situ in the contralateral testicle in patients with testicular cancer: a population-based study.
Kier MGG; Lauritsen J; Almstrup K; Mortensen MS; Toft BG; Rajpert-De Meyts E; Skakkebaek NE; Rørth M; von der Maase H; Agerbaek M; Holm NV; Andersen KK; Dalton SO; Johansen C; Daugaard G
Ann Oncol; 2015 Apr; 26(4):737-742. PubMed ID: 25542924
[TBL] [Abstract][Full Text] [Related]
2. Contralateral biopsies in patients with testicular germ cell tumours: patterns of care in Germany and recent data regarding prevalence and treatment of testicular intra-epithelial neoplasia.
Ruf CG; Gnoss A; Hartmann M; Matthies C; Anheuser P; Loy V; Pichlmeier U; Dieckmann KP
Andrology; 2015 Jan; 3(1):92-8. PubMed ID: 25146646
[TBL] [Abstract][Full Text] [Related]
3. Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients.
von der Maase H; Rørth M; Walbom-Jørgensen S; Sørensen BL; Christophersen IS; Hald T; Jacobsen GK; Berthelsen JG; Skakkebaek NE
Br Med J (Clin Res Ed); 1986 Nov; 293(6559):1398-401. PubMed ID: 3026550
[TBL] [Abstract][Full Text] [Related]
4. Incidence and clinical pattern of contralateral synchronous and metachronous germ cell testicular cancer.
Maroto P; García Del Muro X; Valverde C; Pinto A; Sanchez A; Guma J; Alonso T; Martínez Del Prado P; Vazquez S; Mellado B; Aparicio J; Fernandez-Aramburo A; Girones R; Terrasa J;
Urol Oncol; 2021 Feb; 39(2):135.e17-135.e23. PubMed ID: 33189529
[TBL] [Abstract][Full Text] [Related]
5. Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men.
Fosså SD; Chen J; Schonfeld SJ; McGlynn KA; McMaster ML; Gail MH; Travis LB
J Natl Cancer Inst; 2005 Jul; 97(14):1056-66. PubMed ID: 16030303
[TBL] [Abstract][Full Text] [Related]
6. Further practical experiences in the recognition and management of carcinoma in situ of the testis.
Mumperow E; Lauke H; Holstein AF; Hartmann M
Urol Int; 1992; 48(2):162-6. PubMed ID: 1374974
[TBL] [Abstract][Full Text] [Related]
7. Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols.
Tandstad T; Solberg A; Håkansson U; Stahl O; Haugnes HS; Oldenburg J; Dahl O; Kjellman A; Angelsen A; Cohn-Cedermark G;
Acta Oncol; 2015 Apr; 54(4):493-9. PubMed ID: 25192551
[TBL] [Abstract][Full Text] [Related]
8. Sperm concentration, testicular volume and age predict risk of carcinoma in situ in contralateral testis of men with testicular germ cell cancer.
Rud CN; Daugaard G; Rajpert-De Meyts E; Skakkebæk NE; Petersen JH; Jørgensen N
J Urol; 2013 Dec; 190(6):2074-80. PubMed ID: 23770148
[TBL] [Abstract][Full Text] [Related]
9. [Early detection of a contralateral second carcinoma in patients with testicular tumors caused by testicular carcinoma in situ].
Kleinschmidt K; Weissbach L; Holstein AF
Urologe A; 1989 Sep; 28(5):281-4. PubMed ID: 2573191
[TBL] [Abstract][Full Text] [Related]
10. Screening for carcinoma in situ of the contralateral testis in patients with germinal testicular cancer.
Berthelsen JG; Skakkebaek NE; von der Maase H; Sørensen BL; Mogensen P
Br Med J (Clin Res Ed); 1982 Dec; 285(6356):1683-6. PubMed ID: 6129027
[TBL] [Abstract][Full Text] [Related]
11. Treatment options for carcinoma in situ testis.
Mortensen MS; Gundgaard MG; Daugaard G
Int J Androl; 2011 Aug; 34(4 Pt 2):e32-6. PubMed ID: 21651575
[TBL] [Abstract][Full Text] [Related]
12. Contralateral testicular biopsy in testis cancer: current concepts and controversies.
Heidenreich A
BJU Int; 2009 Nov; 104(9 Pt B):1346-50. PubMed ID: 19840011
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and Management of Intratubular Germ Cell Neoplasia In Situ: A Systematic Review.
Gupta M; Cheaib JG; Patel HD; Sharma R; Zhang A; Bass EB; Pierorazio PM
J Urol; 2020 Jul; 204(1):33-41. PubMed ID: 31967523
[TBL] [Abstract][Full Text] [Related]
14. Risk and prognostic significance of metachronous contralateral testicular germ cell tumours.
Schaapveld M; van den Belt-Dusebout AW; Gietema JA; de Wit R; Horenblas S; Witjes JA; Hoekstra HJ; Kiemeney LA; Louwman WJ; Ouwens GM; Aleman BM; van Leeuwen FE
Br J Cancer; 2012 Oct; 107(9):1637-43. PubMed ID: 23059747
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of contralateral testicular intraepithelial neoplasia (carcinoma in situ) in patients with testicular germ cell tumour. Results of the German multicentre study.
Loy V; Dieckmann KP
Eur Urol; 1993; 23(1):120-2. PubMed ID: 8386640
[TBL] [Abstract][Full Text] [Related]
16. Carcinoma in situ of the testis: biology, screening and management.
Giwercman A; Skakkebaek NE
Eur Urol; 1993; 23 Suppl 2():19-21. PubMed ID: 8390358
[No Abstract] [Full Text] [Related]
17. Risk of bilateral testicular germ cell cancer in Denmark: 1960-1984.
Osterlind A; Berthelsen JG; Abildgaard N; Hansen SO; Hjalgrim H; Johansen B; Munck-Hansen J; Rasmussen LH
J Natl Cancer Inst; 1991 Oct; 83(19):1391-5. PubMed ID: 1656057
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological and clinical aspects of carcinoma in situ of the testis.
Giwercman A; von der Maase H; Skakkebaek NE
Eur Urol; 1993; 23(1):104-10; discussion 111-4. PubMed ID: 8477770
[TBL] [Abstract][Full Text] [Related]
19. Is a contralateral testicular biopsy in patients with unilateral germ cell testicular cancer indicated as a routine procedure?
von der Maase H
Acta Oncol; 2005; 44(6):523-5. PubMed ID: 16165909
[No Abstract] [Full Text] [Related]
20. Carcinoma in situ of the testis: review of biological and clinical features.
Dieckmann KP; Skakkebaek NE
Int J Cancer; 1999 Dec; 83(6):815-22. PubMed ID: 10597201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
